The objective of this IAA is to develop critical reagents (to include inactivated antigenic materials, nucleic acids, and antibodies), which are required for the detection and identification of biological defense agents.
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
Y01
-
Administering IC
AI
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
150000
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
855
-
Ed Inst. Type
-
Funding ICs
NIAID:150000\
-
Funding Mechanism
Contracts, Extramural
-
Study Section
-
Study Section Name